NASDAQ
BioXcel Therapeutics, Inc. (BTAI) has a free cash flow growth of 16.90% as of Friday, May 29, 2026. This represents a 727.15% increase compared to its 12-month average of -2.69%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.